{"id":"W4411010011","doi":"10.1007/s11523-025-01154-4","title":"A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bayer","keywords":"Medicine; Antibody; Bay; Solid tumor; Cancer research; Oncology; Internal medicine; Immunology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141116,0.001215457,0.002124329,0.0004065159,0.0004292056,0.0008535408,0.0007483274,0.0009266947,0.002540882],"category_scores_gemma":[0.0005969045,0.000553631,0.001266402,0.0004826066,0.0008052614,0.0006703575,0.0003374747,0.003143074,0.0007878757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009028543,"about_ca_system_score_gemma":0.001486823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002252792,"about_ca_topic_score_gemma":0.004597893,"domain_scores_codex":[0.9996561,0.0001518744,0.00001203579,0.00005786734,0.00002893076,0.00009324022],"domain_scores_gemma":[0.9995638,0.00006161528,0.00005424513,0.00003988073,0.00002657088,0.0002539458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5041862,0.1242125,0.00961695,0.001616567,0.00220884,0.0007324312,0.0006046094,0.006273162,0.1195671,0.0006705883,0.009299128,0.2210119],"study_design_scores_gemma":[0.3050183,0.6606973,0.01554118,0.00004091953,0.0007443005,0.0005591322,0.0001019985,0.002286758,0.007388778,0.0002064209,0.007372363,0.00004253408],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889108,0.00413488,0.0008710123,0.0005540426,0.0002501194,0.001776924,0.0007886787,0.0001350606,0.002578473],"genre_scores_gemma":[0.9850996,0.004476518,0.001822504,0.0009244375,0.0002198101,0.001534251,0.002174309,0.00005236046,0.003696081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002540882,"threshold_uncertainty_score":0.008500099,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01097801612756192,"score_gpt":0.3780891252964261,"score_spread":0.3671111091688642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}